Azenta (AZTA) Cash & Equivalents (2010 - 2026)
Azenta's (AZTA) quarterly Cash & Equivalents came in at $234.0 million in Q1 2026, down 7.73% year-on-year from $253.6 million in Q1 2025, and down 30.48% on a QoQ basis from $336.6 million in Q4 2025.
Azenta (AZTA) Cash & Equivalents (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Cash & Equivalents data on file, last reported at $234.0 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 7.73% year-over-year to $234.0 million in Q1 2026; TTM through Mar 2026 was $234.0 million, a 7.73% decrease from a year earlier, with the FY2025 full-year figure at $336.6 million, changed N/A from the prior year.
- Cash & Equivalents for Q1 2026 stood at $234.0 million, down from $336.6 million in the prior quarter.
- Over the last five years, Cash & Equivalents for AZTA reached as high as $1.9 billion in Q1 2022 and fell as low as $234.0 million in Q1 2026.
- Historically, Cash & Equivalents has averaged $597.2 million across 5 years, with a median of $377.5 million in 2024.
- Across the five-year window, Cash & Equivalents soared 504.89% in 2022 and slumped 65.53% in 2023, its largest moves.
- Year by year, Cash & Equivalents stood at $608.3 million in 2022, then advanced by 15.55% to $702.9 million in 2023, then plunged by 46.3% to $377.5 million in 2024, then declined by 10.82% to $336.6 million in 2025, then plunged by 30.48% to $234.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $234.0 million in Q1 2026, $336.6 million in Q4 2025, and $279.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 813.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 1.58 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Azenta | 1.28 Bn | 1.04 Bn | 125.74 Mn | 234.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.03 Mn |
| Dec 31, 2025 | 336.63 Mn |
| Sep 30, 2025 | 279.78 Mn |
| Jun 30, 2025 | 270.04 Mn |
| Mar 31, 2025 | 253.64 Mn |
| Dec 31, 2024 | 377.49 Mn |
| Sep 30, 2024 | 280.03 Mn |
| Jun 30, 2024 | 336.54 Mn |
| Mar 31, 2024 | 353.49 Mn |
| Dec 31, 2023 | 702.92 Mn |
| Sep 30, 2023 | 649.48 Mn |
| Jun 30, 2023 | 733.37 Mn |
| Mar 31, 2023 | 667.37 Mn |
| Dec 31, 2022 | 608.30 Mn |
| Sep 30, 2022 | 658.27 Mn |
| Jun 30, 2022 | 1.47 Bn |
| Mar 31, 2022 | 1.94 Bn |
| Dec 31, 2021 | 215.17 Mn |
| Sep 30, 2021 | 227.43 Mn |
| Jun 30, 2021 | 269.86 Mn |